Cargando…
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
CUB-domain containing protein 1 (CDCP1) is a cancer associated cell surface protein that amplifies pro-tumorigenic signalling by other receptors including EGFR and HER2. Its potential as a cancer target is supported by studies showing that anti-CDCP1 antibodies inhibit cell migration and survival in...
Autores principales: | Harrington, Brittney S., He, Yaowu, Khan, Tashbib, Puttick, Simon, Conroy, Paul J., Kryza, Thomas, Cuda, Tahleesa, Sokolowski, Kamil A, Tse, Brian WC, Robbins, Katherine K., Arachchige, Buddhika J., Stehbens, Samantha J., Pollock, Pamela M., Reed, Sarah, Weroha, S. John, Haluska, Paul, Salomon, Carlos, Lourie, Rohan, Perrin, Lewis C., Law, Ruby H. P., Whisstock, James C., Hooper, John D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019151/ https://www.ncbi.nlm.nih.gov/pubmed/32104500 http://dx.doi.org/10.7150/thno.30736 |
Ejemplares similares
-
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
por: Cuda, Tahleesa J., et al.
Publicado: (2021) -
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020) -
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy
por: Khan, Tashbib, et al.
Publicado: (2022) -
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma
por: Khan, Tashbib, et al.
Publicado: (2020) -
New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways
por: He, Yaowu, et al.
Publicado: (2016)